CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials KF Schulz, DG Altman, D Moher Journal of Pharmacology and pharmacotherapeutics 1 (2), 100-107, 2010 | 24440 | 2010 |
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement D Moher, A Liberati, J Tetzlaff, DG Altman, Prisma Group International journal of surgery 8 (5), 336-341, 2010 | 12690 | 2010 |
CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials D Moher, S Hopewell, KF Schulz, V Montori, PC Gøtzsche, PJ Devereaux, ... Bmj 340, 2010 | 12678* | 2010 |
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide TC Hoffmann, PP Glasziou, I Boutron, R Milne, R Perera, D Moher, ... Bmj 348, 2014 | 8601 | 2014 |
CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration S Hopewell, M Clarke, D Moher, E Wager, P Middleton, DG Altman, ... PLoS medicine 5 (1), e20, 2008 | 775 | 2008 |
The Hong Kong Principles for assessing researchers: Fostering research integrity D Moher, L Bouter, S Kleinert, P Glasziou, MH Sham, V Barbour, ... PLoS biology 18 (7), e3000737, 2020 | 466 | 2020 |
Potential predatory and legitimate biomedical journals: can you tell the difference? A cross-sectional comparison L Shamseer, D Moher, O Maduekwe, L Turner, V Barbour, R Burch, ... BMC medicine 15, 1-14, 2017 | 444 | 2017 |
Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration V Welch, M Petticrew, J Petkovic, D Moher, E Waters, H White, P Tugwell, ... Journal of clinical epidemiology 70, 68-89, 2016 | 274 | 2016 |
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide TC Hoffmann, PP Glasziou, I Boutron, R Milne, R Perera, D Moher, ... Gesundheitswesen (Bundesverband der Arzte des Offentlichen …, 2016 | 201* | 2016 |
Retractions: guidance from the Committee on Publication Ethics (COPE) E Wager, V Barbour, S Yentis, S Kleinert Maturitas 64 (4), 201-203, 2009 | 168 | 2009 |
UK Biobank: a project in search of a protocol? V Barbour The Lancet 361 (9370), 1734-1738, 2003 | 122 | 2003 |
Making sense of non-financial competing interests PLoS Medicine Editors PLoS Medicine 5 (9), e199, 2008 | 111 | 2008 |
Time to treat the climate and nature crisis as one indivisible global health emergency K Abbasi, P Ali, V Barbour, T Benfield, K Bibbins-Domingo, S Hancocks, ... Nutrition Reviews 82 (11), 1457-1459, 2024 | 108 | 2024 |
Nephrotic syndrome associated with sulphasalazine. VM Barbour, PF Williams BMJ: British Medical Journal 301 (6755), 818, 1990 | 72 | 1990 |
Core competencies for scientific editors of biomedical journals: consensus statement D Moher, J Galipeau, S Alam, V Barbour, K Bartolomeos, P Baskin, ... BMC medicine 15, 1-10, 2017 | 71 | 2017 |
α-Thalassemia resulting from a negative chromosomal position effect VM Barbour, C Tufarelli, JA Sharpe, ZE Smith, H Ayyub, CA Heinlein, ... Blood, The Journal of the American Society of Hematology 96 (3), 800-807, 2000 | 60 | 2000 |
A scoping review of competencies for scientific editors of biomedical journals J Galipeau, V Barbour, P Baskin, S Bell-Syer, K Cobey, M Cumpston, ... BMC medicine 14, 1-17, 2016 | 59 | 2016 |
Optimal evidence in difficult settings: improving health interventions and decision making in disasters M Gerdin, M Clarke, C Allen, B Kayabu, W Summerskill, D Devane, ... PLoS medicine 11 (4), e1001632, 2014 | 59 | 2014 |
Impact of a web-based tool (WebCONSORT) to improve the reporting of randomised trials: results of a randomised controlled trial S Hopewell, I Boutron, DG Altman, G Barbour, D Moher, V Montori, ... BMC medicine 14, 1-17, 2016 | 54 | 2016 |
Characterisation of trials where marketing purposes have been influential in study design: a descriptive study V Barbour, D Burch, F Godlee, C Heneghan, R Lehman, R Perera, ... Trials 17, 1-10, 2016 | 47 | 2016 |